Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F5ZVD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $188,020
Award facts
- Contract value 100% obligated
- $188,020.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $188,020.49 for the supply of Keytruda (pembrolizumab) 100 mg/4 ml vials. The contract, awarded on April 21, 2025, with an ultimate completion date of May 12, 2025, is funded by the Department of Defense's Medical Supply Chain and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military healthcare facilities.
Keytruda is a widely used oncology medication indicated for various cancer treatments, and this delivery supports the Department of Defense's pharmaceutical supply chain for military medical facilities nationwide. DMS Pharmaceutical Group has established itself as a significant federal pharmaceutical supplier, with a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables. The company's positioning as a certified woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining consistent engagement with the DLA's medical supply needs.
Quick answers
Who was awarded contract SPE2DX25F5ZVD?
SPE2DX25F5ZVD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on April 21, 2025.
How much is contract SPE2DX25F5ZVD worth?
The government has obligated $188,020 on SPE2DX25F5ZVD.
Is contract SPE2DX25F5ZVD an order under another contract?
Yes. SPE2DX25F5ZVD is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZVD competed?
The extent of competition for SPE2DX25F5ZVD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award